Nida data, statistics, and clinical trial support center management and support. 03/01/2020 - 02/28/2021. N01DA-19-2250. Task order 75N95020F00001 (TO12).
Ended Awarded Last action
- Contract number
- 75N95020F00001
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,645,396
Award facts
- Opportunity
-
- TORFP75N95020F00001 Solicitation number
- Contract value 100% obligated
- $2,645,396.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$16,987 | |
| Exercise an Option | $549,285 | |
| Exercise an Option | $183,095 | |
| Original award | $1,930,003 |
About this award
This is a federal contract award to The Emmes Company LLC, a global clinical research organization, by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services. The contract, valued at $2,645,396.13, is for the NIDA Data, Statistics, and Clinical Trial Support Center Management and Support, covering the period from March 1, 2020, to February 28, 2021. This is a cost-plus-fixed-fee type contract, with no set-aside designation. The Emmes Company LLC has been providing comprehensive research support services to NIDA and other NIH institutes, including biostatistical analysis, data management, clinical trial coordination, and operational oversight for complex biomedical research initiatives. The company has several significant Indefinite Delivery Vehicle (IDV) contracts with federal agencies, including a $49.5 million Clinical Coordinating Center contract with NIDA, enabling it to provide rapid and flexible support across multiple research domains related to substance abuse and drug abuse treatment.
Quick answers
Who was awarded contract 75N95020F00001?
75N95020F00001 was awarded to The Emmes Company, LLC by National Institute on Drug Abuse (National Institutes of Health) on March 1, 2020.
How much is contract 75N95020F00001 worth?
The government has obligated $2,645,396 on 75N95020F00001.
Is contract 75N95020F00001 an order under another contract?
Yes. 75N95020F00001 is a delivery order under 75N95019D00013, an indefinite delivery contract.
Was contract 75N95020F00001 competed?
The extent of competition for 75N95020F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award